Il-17 inhibitor in patient with juvenile psoriasis and primary immunodeficiency.

Sestan, Mario; Frkovic, Marijan; Ceovic, Romana; Murat-Susic, Slobodna; Jelusic, Marija

Sestan, Mario; Frkovic, Marijan; Ceovic, Romana; Murat-Susic, Slobodna; Jelusic, Marija.

Afiliación

Sestan M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Frkovic M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Ceovic R; Department of Dermatology and Venerology, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Murat-Susic S; Department of Dermatology and Venerology, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Jelusic M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.

Pediatr Allergy Immunol ; 35(1): e14074, 2024 Jan.

Article en En | MEDLINE | ID: mdl-38284921

Asunto(s)

Interleucina-17; Enfermedades de Inmunodeficiencia Primaria; Psoriasis; Humanos; Psoriasis/tratamiento farmacológico; Interleucina-17/antagonistas & inhibidores; Enfermedades de Inmunodeficiencia Primaria/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Interleucina-17 / Enfermedades de Inmunodeficiencia Primaria Límite: Humans Idioma: En Revista: Pediatr Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Croacia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google